Published in Chem Immunol Allergy on January 01, 2006
State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve? Blood Transfus (2011) 0.88
Histamine: a new immunomodulatory player in the neuron-glia crosstalk. Front Cell Neurosci (2014) 0.86
Characterization and function of histamine receptors in human bone marrow stromal cells. Stem Cells (2012) 0.85
Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells. Immunology (2011) 0.81
An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability. BMC Syst Biol (2011) 0.80
H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.79
Endobiogeny: a global approach to systems biology (part 2 of 2). Glob Adv Health Med (2013) 0.78
Eosinophils and mast cells in leishmaniasis. Immunol Res (2014) 0.77
Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-/- mice. PLoS One (2014) 0.76
Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice. Dose Response (2015) 0.75
Thermographic assessment of skin prick tests in comparison with the routine evaluation methods. Postepy Dermatol Alergol (2016) 0.75
Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells. J Cereb Blood Flow Metab (2012) 0.75
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol (2006) 3.09
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol (2007) 2.49
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol (2011) 2.06
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2007) 2.05
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol (2013) 1.96
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol (2004) 1.92
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med (2008) 1.91
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol (2012) 1.88
Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol (2002) 1.82
Role of Treg in immune regulation of allergic diseases. Eur J Immunol (2010) 1.82
TH17 cells in the big picture of immunology. J Allergy Clin Immunol (2007) 1.78
IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol (2005) 1.74
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J (2002) 1.66
Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med (2009) 1.57
Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol (2006) 1.45
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol (2013) 1.43
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2013) 1.36
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol (2010) 1.34
Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol (2006) 1.34
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. J Allergy Clin Immunol (2012) 1.28
T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J (2003) 1.24
Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol (2009) 1.24
Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol (2011) 1.20
Regulatory NK cells suppress antigen-specific T cell responses. J Immunol (2008) 1.18
Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol (2004) 1.18
Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol (2005) 1.17
Immune regulation by histamine. Curr Opin Immunol (2002) 1.16
MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol (2013) 1.16
Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol (2005) 1.14
Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol (2003) 1.14
TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol (2011) 1.12
Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol (2003) 1.12
T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol (2002) 1.11
TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol (2012) 1.11
Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J Immunol (2009) 1.10
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
T-cell subset regulation in atopy. Curr Allergy Asthma Rep (2011) 1.09
IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol (2011) 1.08
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol (2007) 1.08
Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res (2010) 1.07
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. J Immunol (2009) 1.04
Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol (2005) 1.03
Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol (2008) 1.03
Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest (2014) 1.03
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol (2011) 1.01
Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep (2013) 1.01
Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol (2012) 0.99
Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J Allergy Clin Immunol (2013) 0.98
Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. J Allergy Clin Immunol (2009) 0.97
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol (2011) 0.95
Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol (2006) 0.94
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol (2012) 0.93
Mechanisms of immune tolerance to allergens. Chem Immunol Allergy (2012) 0.93
Apoptosis in tissue inflammation and allergic disease. Curr Opin Immunol (2004) 0.93
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter. J Immunol (2010) 0.92
T-cell regulatory mechanisms in specific immunotherapy. Chem Immunol Allergy (2008) 0.92
MicroRNAs in allergy and asthma. Curr Allergy Asthma Rep (2014) 0.91
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int Arch Allergy Immunol (2005) 0.91
TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes. Am J Physiol Lung Cell Mol Physiol (2006) 0.91
Dual nature of T cell-epithelium interaction in chronic rhinosinusitis. J Allergy Clin Immunol (2009) 0.91
Portrait of an immunoregulatory Bifidobacterium. Gut Microbes (2012) 0.91
T regulatory cells in allergy. Chem Immunol Allergy (2006) 0.90
Mechanisms of subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am (2011) 0.90
Comparison of the crystal structures of the human manganese superoxide dismutase and the homologous Aspergillus fumigatus allergen at 2-A resolution. J Immunol (2002) 0.90
Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol (2002) 0.89
T-cell subsets in the pathogenesis of human asthma. Curr Allergy Asthma Rep (2006) 0.89
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. J Allergy Clin Immunol (2005) 0.89
Specific immunotherapy and turning off the T cell: how does it work? Ann Allergy Asthma Immunol (2011) 0.89
T regulatory cells and allergy. Microbes Infect (2005) 0.89